Julius Gene S Latorre, MD, MPH

Julius Gene S Latorre, MD, MPH
Appointed 07/01/00
7134UH Upstate University Hospital - Downtown Campus
750 East Adams Street
Syracuse, NY 13210

315 464-5014

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Neurology: Cerebrovascular

Research Programs and Affiliations

  • Neurology

Clinic/Unit

Web Resources

Education & Fellowships

  • Additional Training: Harvard School of Public Health, 2008, Clinical Effectiveness
  • Fellowship: Massachusetts General Hospital, 2007, Neurocritical Care
  • Fellowship: Massachusetts General Hospital, 2006, Vascular Neurology
  • Fellowship: SUNY Health Science Center at Syracuse, 2005, Clinical Neurophysiology
  • Residency: SUNY Upstate Medical University, 2004, Neurology
  • Internship: SUNY Upstate Medical Center, 2001, Medicine
  • MD: University of the East-Ramon Magsaysay Memorial Medical Center, 1995

Previous Appointments

  • Massachusetts General Hospital/Havard Medical School, 2005–2007

Clinical Interests

  • Management of Subarachnoid hemorrhage, acute ischemic and hemorrhagic strokes, traumatic brain injuries, nontraumatic encephalopathies, encephalitides, status epilepticus, post-cardiac arrest coma management.

Research Interests

  • Multimodality neuromonitoring, advanced neurophysiologic monitoring, intensive insulin therapy for SAH, IV and IA thrombolysis for acute ischemic strokes, Moderate hypothermia

Specialties & Certification

  • Neurology
  • Clinical Neurophysiology
  • Vascular Neurology
  • Neurocritical Care

Diseases & Conditions Treated

  • Brain Injury
  • Guillain Barre Syndrome
  • Myasthenia Gravis
  • Status Epilepticus
  • Stroke

Treats

  • Adults and Children

Treatments/Services

  • Electroencephalogram (EEG)
  • Electromyography (EMG)
  • Fiberoptic Bronchoscopy
  • Hydrocephalus Treatment
  • Lumbar Puncture
  • Nerve Conduction Study/Testing
  • Transcranial Doppler Exam
  • Ventilator Management

Associations/Memberships

  • American Academy of Neurology (AAN)
  • American Heart Association (AHA)
  • Society of Critical Care Medicine

Current Hospital Privileges

  • Upstate University Hospital

Languages Spoken (Other Than English)

  • Tagalog

Web Resources

Publications

Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Title: Predictors of early and late vasospasm in Aneurysmal Subarachnoid Hemorrhage

Background:The peak incidence of vasospasm in aneurysmal subarachnoid hemorrhage occurs between the fourth and 10th day post bleed, occurring in up to 70% of patients.1  Occasionally patients develop early (within 48 hours) or late (beyond 10 days) from initial aneurysm rupture.  Different mechanisms account for the temporal differences in occurrence of vasospasm in aneurysmal subarachnoid hemorrhage.2 The purpose of this study is to determine predictors of early and late vasospasm to select patients who may benefit from early intervention (for patients at risk for early vasospasm) or prolonged observation (for patients at risk for late vasospasm).  Hypothesis:We hypothesize that we can identify clinical predictors of early and late vasospasm in aneurysmal subarachnoid hemorrhage. Methods: 226 consecutive patients with aneurysmal subarachnoid hemorrhage who developed vasospasm were studied.  Patients were grouped into two categories.  Patients who developed vasospasm within 48 hours or beyond 10 days from suspected aneurysmal rupture and were compared to the rest of the cohort. Potential predictors were identified using univariate screen. Multivariable logistic regression models were then used to determine the independent effect of each predictors and adjusted for age, sex, method of aneurysm repair, Hunt and Hess grade and Fisher group. Results: 28 patients out of 226 developed early vasospasm.  Fisher group (OR 3.4, 95% CI [1.1, 10.5], p = 0.03), early evidence of infarction on admission CT (OR 1.7, 95% CI [1.1, 24.5], p = 0.03),  and aneurysm size (OR 1.1 for every mm increase in size above 7mm, 95% CI [1.0, 1.2], p = 0.03) appear to be independent predictor of early vasospasm.  Early intensive insulin treatment is associated with reduced risk for early vasospasm (OR 0.3, 95% CI [0.1, 0.8], p = 0.02). Occurrence of early vasospasm independently increased the risk of poor outcome (OR 8.4, 95% CI [2.4, 29.9], p <0.01). 13 patients out of 226 developed late vasospasm. Age was found to be an independent predictor of late vasospasm, increasing risk by 7.2% (95% CI [1.6, 13.1], p = 0.01) for every year above 50.  Blood transfusion appear to be protective for late vasospasm (OR 0.2, 95% CI [0.05, 0.77], p = 0.02). The occurrence of late vasospasm did not increase the risk of poor outcome. Conclusion:  Patient characteristics may predict early or delayed vasospasm.  Early vasospasm is a an independent risk factor for poor outcome. Early treatment of hyperglycemia with insulin suggest protective effect but does not prevent delayed vasospasm.  More research is needed to determine the true relationship of aneurysm size and age in predicting vasospasm, and of hyperglycemia management and blood transfusion in preventing vasospasm.

Clinical Profile Shortcut: http://www.upstate.edu/findadoc/latorrej
Faculty Profile Shortcut: http://www.upstate.edu/faculty/latorrej
Sue Stearns, PhD

Sue Stearns, PhD
Associate Professor of Cell and Developmental Biology

Sue Stearns, PhD, is one of four faculty members who teach Gross Anatomy to first-year medical students at SUNY Upstate. Students routinely cite this course as a favorite.

Steven Youngentob, PhD

Steven Youngentob, PhD
Associate Dean of Basic Research and Graduate Studies

Steven Youngentob, PhD, is at the forefront of research into alcohol addiction.

Download the MD/PhD 2013-14 Brochure. PDF document